For treatment of: Mexiprim nootropics nervous system, brain.Mexiprim nootropics
- For the treatment of internal organs: nervous system, brain
- Appointment: stress, cognitive impairment, memory improvement, alcohol withdrawal syndrome, treatment and prevention of cerebral circulatory disorders, autonomic (neurocirculatory) dystonia syndrome, anxiety disorders in neurotic and neurosis-like conditions, neurocirculatory dystonia, psychoorganic syndrome
- Indications for use:
Anxiety disorders in neurotic and neurosis-like conditions;
— vegetative-vascular dystonia;
— mild cognitive disorders of various origins (in psychoorganic syndrome and asthenic disorders caused by acute and chronic disorders of cerebral circulation, traumatic brain injuries, neuroinfections and intoxications, senile and atrophic processes);
— memory disorders and intellectual disability in the elderly;
— exposure to extreme (stressful) factors;
— withdrawal syndrome in alcoholism with a predominance of neurosis-like and vegetative-vascular disorders.
— renal failure;
— breast-feeding period;
active substance: Ethylmethylhydroxypyridine succinate in terms of 100% substance 0.125 g; excipients (tablet core): kaolin 0.00247 g, sodium carboxymethyl starch 0.01258 g, microcrystalline cellulose 0.1135 g, povidone 0.0134 g, talc 0.0053 g, calcium stearate 0.00275 g; excipients (shell): hypromellose 0.00495 g, macrogol 0.00128 g, titanium dioxide 0.00165 g, talc 0.00037 g.
- Manufacturer: CIS STADA